AJP - Heart AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 295: H2250-H2256, 2008. First published October 3, 2008; doi:10.1152/ajpheart.00083.2008
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/H2250    most recent
00083.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hao, Q.
Right arrow Articles by Yang, G.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hao, Q.
Right arrow Articles by Yang, G.-Y.

Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation

Qi Hao,1 Hua Su,2 Douglas A. Marchuk,6 Radoslaw Rola,3 Yongqiang Wang,5 Weizhong Liu,1 William L. Young,1,3,4 and Guo-Yuan Yang1,3

1Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care; 2Cardiovascular Research Institute; Departments of 3Neurological Surgery, 4Neurology, 5Cellular and Molecular Pharmacology, University of California, San Francisco, California; and 6Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina

Submitted 25 January 2008 ; accepted in final form 25 September 2008

Loss-of-function activin receptor-like kinase 1 gene mutation (ALK1+/–) is associated with brain arteriovenous malformations (AVM) in hereditary hemorrhagic telangiectasia type 2. Other determinants of the lesional phenotype are unknown. In the present study, we investigated the influence of high vascular flow rates on ALK1+/– mice by manipulating cerebral blood flow (CBF) using vasodilators. Adult male ALK1+/– mice underwent adeno-associated viral-mediated vascular endothelial growth factor (AAVVEGF) or lacZ (AAVlacZ as a control) gene transfer into the brain. Two weeks after vector injection, hydralazine or nicardipine was infused intraventricularly for another 14 days. CBF was measured to evaluate relative tissue perfusion. We analyzed the number and morphology of capillaries. Results demonstrated that hydralazine or nicardipine infusion increased focal brain perfusion in all mice. It was noted that focal CBF increased most in AAVVEGF-injected ALK1+/– mice following hydralazine or nicardipine infusion (145 ± 23% or 150 ± 11%; P < 0.05). There were more detectable dilated and dysplastic capillaries (2.4 ± 0.3 or 2.0 ± 0.4 dysplasia index; P < 0.01) in the brains of ALK1+/– mice treated with AAVVEGF and hydralazine or nicardipine compared with the mice treated with them individually. We concluded that increased focal tissue perfusion and angiogenic factor VEGF stimulation could have a synergistic effect to promote capillary dysplasia in a genetic deficit animal model, which may have relevance to further studies of AVMs.

activin receptor-like kinase 1; angiogenesis; vascular endothelial growth factor



Address for reprint requests and other correspondence: G.-Y. Yang, Univ. of California, San Francisco, Dept. of Anesthesia and Perioperative Care, 1001 Potrero Ave., Rm. 3C-38, San Francisco, CA 94110 (e-mail: ccr{at}anesthesia.ucsf.edu)




This article has been cited by other articles:


Home page
StrokeHome page
G. G. Leblanc, E. Golanov, I. A. Awad, W. L. Young, and Biology of Vascular Malformations of the Brain NIN
Biology of Vascular Malformations of the Brain
Stroke, December 1, 2009; 40(12): e694 - e702.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.